Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Slightly Bullish +15

Intuitive Surgical, Inc. $ISRG Shares Sold by BSN CAPITAL PARTNERS Ltd

📉 BSN Capital Partners reduced its ISRG position by 41.5%, selling 71,000 shares to hold 100,000 shares valued at $49.6 million.

📈 Norges Bank established a new massive position worth $2.86 billion in the fourth quarter.

🚀 J. Stern & Co. LLP increased its stake by 18,504.6% to own 2.13 million shares valued at $1.2 billion.

📈 Northwestern Mutual Wealth Management raised its holdings by 1,043.3% to acquire an additional 1.22 million shares.

📈 Arrowstreet Capital Limited Partnership increased its position by 95.3% in the first quarter.

📉 Deutsche Bank lowered its price target from $440 to $366 and issued a sell rating.

📉 HSBC downgraded Intuitive Surgical from a buy to a hold with a $391 price objective.

📈 Barclays maintains an overweight rating with a high $651 price target.

📊 The stock currently trades at a PE ratio of 40.47 with a market cap of $124.82 billion.

💼 Insiders sold a total of 6,634 shares valued at $2.8 million over the last ninety days.

Bullish Signals
  • Major institutional investors like Norges Bank and J. Stern & Co. have significantly increased their stakes, indicating strong confidence in the company's long-term prospects.
  • Northwestern Mutual Wealth Management added over 1.2 million shares to its portfolio, representing a massive increase of more than 1,000%.
Risk Factors
  • Deutsche Bank and HSBC have downgraded their ratings or lowered price targets, signaling potential concerns about the current valuation or growth trajectory.
  • Insiders sold $2.8 million worth of stock in the last ninety days, which can sometimes indicate a lack of immediate confidence at the executive level.
Full Analysis
Intuitive Surgical (ISRG) saw significant institutional activity in recent quarters, highlighted by BSN Capital Partners reducing its stake by 41.5% to 100,000 shares worth $49.6 million. Conversely, major funds like Norges Bank, J. Stern & Co., and Northwestern Mutual Wealth Management aggressively increased their holdings, with J. Stern raising its position by over 18,500% to own more than $1.2 billion in stock. Analyst sentiment remains mixed regarding the company's valuation. While Barclays maintains an overweight rating with a $651 price target, Deutsche Bank and HSBC have downgraded their ratings or lowered targets to the low $300s. The consensus among twenty analysts is currently a Moderate Buy with an average price target of $509.02. Insider trading data shows recent sales by executives Iman Jeddi and Gary Loeb, who sold shares under pre-arranged Rule 10b5-1 plans. Over the last ninety days, insiders have collectively sold approximately $2.8 million in stock, though they still retain a small 0.60% ownership stake in the company.